Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew M Scott

Showing results (281-290 of 360) with videos related to

Pageof 36
Sort By:
Theranostics|December 8, 2016
<i>In Vitro</i> and <i>In Vivo</i> Evaluation of <sup>89</sup>Zr-DS-8273a as a Theranostic for Anti-Death Receptor 5 TherapyIngrid J G Burvenich, Fook-Thean Lee, Nancy Guo, et al.
The Journal of Clinical Investigation|January 27, 2007
Therapeutic anti-EGFR antibody 806 generates responses in murine de novo EGFR mutant-dependent lung carcinomasDanan Li, Hongbin Ji, Sara Zaghlul, et al.
Molecular Pharmaceutics|July 8, 2014
Single-chain antibody conjugated to a cage amine chelator and labeled with positron-emitting copper-64 for diagnostic imaging of activated plateletsKaren Alt, Brett M Paterson, Katie Ardipradja, et al.
Nuclear Medicine and Biology|May 24, 2023
Automated radiosynthesis of [<sup>89</sup>Zr]Zr-DFOSq-Durvalumab for imaging of PD-L1 expressing tumours in vivoChristian W Wichmann, Stan Poniger, Nancy Guo, et al.
International Journal of Cancer|March 29, 2002
Novel monoclonal antibody specific for the de2-7 epidermal growth factor receptor (EGFR) that also recognizes the EGFR expressed in cells containing amplification of the EGFR geneTerrance G Johns, Elisabeth Stockert, Gerd Ritter, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|June 8, 2023
Influence of molecular imaging on patient selection for treatment intensification prior to salvage radiation therapy for prostate cancer: a post hoc analysis of the PROPS trialSamuel Tremblay, Mofarej Alhogbani, Andrew Weickhardt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2010
Immuno-PET quantitation of de2-7 epidermal growth factor receptor expression in glioma using 124I-IMP-R4-labeled antibody ch806Fook T Lee, Graeme J O'Keefe, Hui K Gan, et al.
Neuro-Oncology Advances|May 31, 2021
Bintrafusp alfa (M7824), a bifunctional fusion protein targeting TGF-β and PD-L1: results from a phase I expansion cohort in patients with recurrent glioblastomaMustafa Khasraw, Michael Weller, David Lorente, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 22, 2015
PET-based compartmental modeling of (124)I-A33 antibody: quantitative characterization of patient-specific tumor targeting in colorectal cancerPat Zanzonico, Jorge A Carrasquillo, Neeta Pandit-Taskar, et al.
The Lancet. Oncology|May 31, 2024
Production and regulatory issues for theranosticsFrancesco Giammarile, Diana Paez, Richard Zimmermann, et al.
Pageof 36

Showing results (281-290 of 360) with videos related to

Sort By:
Pageof 36
Theranostics|December 8, 2016
<i>In Vitro</i> and <i>In Vivo</i> Evaluation of <sup>89</sup>Zr-DS-8273a as a Theranostic for Anti-Death Receptor 5 TherapyIngrid J G Burvenich, Fook-Thean Lee, Nancy Guo, et al.
The Journal of Clinical Investigation|January 27, 2007
Therapeutic anti-EGFR antibody 806 generates responses in murine de novo EGFR mutant-dependent lung carcinomasDanan Li, Hongbin Ji, Sara Zaghlul, et al.
Molecular Pharmaceutics|July 8, 2014
Single-chain antibody conjugated to a cage amine chelator and labeled with positron-emitting copper-64 for diagnostic imaging of activated plateletsKaren Alt, Brett M Paterson, Katie Ardipradja, et al.
Nuclear Medicine and Biology|May 24, 2023
Automated radiosynthesis of [<sup>89</sup>Zr]Zr-DFOSq-Durvalumab for imaging of PD-L1 expressing tumours in vivoChristian W Wichmann, Stan Poniger, Nancy Guo, et al.
International Journal of Cancer|March 29, 2002
Novel monoclonal antibody specific for the de2-7 epidermal growth factor receptor (EGFR) that also recognizes the EGFR expressed in cells containing amplification of the EGFR geneTerrance G Johns, Elisabeth Stockert, Gerd Ritter, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|June 8, 2023
Influence of molecular imaging on patient selection for treatment intensification prior to salvage radiation therapy for prostate cancer: a post hoc analysis of the PROPS trialSamuel Tremblay, Mofarej Alhogbani, Andrew Weickhardt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2010
Immuno-PET quantitation of de2-7 epidermal growth factor receptor expression in glioma using 124I-IMP-R4-labeled antibody ch806Fook T Lee, Graeme J O'Keefe, Hui K Gan, et al.
Neuro-Oncology Advances|May 31, 2021
Bintrafusp alfa (M7824), a bifunctional fusion protein targeting TGF-β and PD-L1: results from a phase I expansion cohort in patients with recurrent glioblastomaMustafa Khasraw, Michael Weller, David Lorente, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 22, 2015
PET-based compartmental modeling of (124)I-A33 antibody: quantitative characterization of patient-specific tumor targeting in colorectal cancerPat Zanzonico, Jorge A Carrasquillo, Neeta Pandit-Taskar, et al.
The Lancet. Oncology|May 31, 2024
Production and regulatory issues for theranosticsFrancesco Giammarile, Diana Paez, Richard Zimmermann, et al.
Pageof 36